in two placebo-controlled , double-blind , randomized trials scopolamine ( 0.3 mg ) alone or combined with ephedrine ( 25 mg ) was tested for its effectiveness in the prevention of seasickness during 24 h at sea and of motion sickness in rotating chair tests in a laboratory .
C0036442
scopolamine
C0026603
motion sickness